154 related articles for article (PubMed ID: 37498063)
1. NOP2-mediated m5C methylation of XPD is associated with hepatocellular carcinoma progression.
Sun GF; Ding H
Neoplasma; 2023 Jun; 70(3):340-349. PubMed ID: 37498063
[TBL] [Abstract][Full Text] [Related]
2. m5C RNA methyltransferase-related gene NSUN4 stimulates malignant progression of hepatocellular carcinoma and can be a prognostic marker.
Cui M; Qu F; Wang L; Liu X; Yu J; Tang Z; Cheng D
Cancer Biomark; 2022; 33(3):389-400. PubMed ID: 34744073
[TBL] [Abstract][Full Text] [Related]
3. NOP2-mediated m5C Modification of c-Myc in an EIF3A-Dependent Manner to Reprogram Glucose Metabolism and Promote Hepatocellular Carcinoma Progression.
Zhang H; Zhai X; Liu Y; Xia Z; Xia T; Du G; Zhou H; Franziska Strohmer D; Bazhin AV; Li Z; Wang X; Jin B; Guo D
Research (Wash D C); 2023; 6():0184. PubMed ID: 37398932
[TBL] [Abstract][Full Text] [Related]
4. Eukaryotic rRNA Modification by Yeast 5-Methylcytosine-Methyltransferases and Human Proliferation-Associated Antigen p120.
Bourgeois G; Ney M; Gaspar I; Aigueperse C; Schaefer M; Kellner S; Helm M; Motorin Y
PLoS One; 2015; 10(7):e0133321. PubMed ID: 26196125
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of key biomarkers based on RNA methylation genes in sepsis.
Zhang Q; Bao X; Cui M; Wang C; Ji J; Jing J; Zhou X; Chen K; Tang L
Front Immunol; 2023; 14():1231898. PubMed ID: 37701433
[TBL] [Abstract][Full Text] [Related]
6. Function of m
Yang S; Zhou D; Zhang C; Xiang J; Xi X
Cancer Biol Ther; 2023 Dec; 24(1):2263921. PubMed ID: 37800580
[TBL] [Abstract][Full Text] [Related]
7. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2.
Wang F; Yuan JH; Wang SB; Yang F; Yuan SX; Ye C; Yang N; Zhou WP; Li WL; Li W; Sun SH
Hepatology; 2014 Oct; 60(4):1278-90. PubMed ID: 25043274
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
[TBL] [Abstract][Full Text] [Related]
9. m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma.
Pan J; Huang Z; Xu Y
Front Oncol; 2021; 11():657466. PubMed ID: 34195072
[TBL] [Abstract][Full Text] [Related]
10. NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma.
Zhang XW; Wu LY; Liu HR; Huang Y; Qi Q; Zhong R; Zhu L; Gao CF; Zhou L; Yu J; Wu HG
Oncol Lett; 2022 Dec; 24(6):439. PubMed ID: 36420066
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic value of m5C regulatory genes in hepatocellular carcinoma.
Yang X; Yang F; Lan L; Wen N; Li H; Sun X
Front Genet; 2022; 13():972043. PubMed ID: 36105093
[No Abstract] [Full Text] [Related]
12. Prognostic Significance and Tumor Immune Microenvironment Heterogenicity of m5C RNA Methylation Regulators in Triple-Negative Breast Cancer.
Huang Z; Pan J; Wang H; Du X; Xu Y; Wang Z; Chen D
Front Cell Dev Biol; 2021; 9():657547. PubMed ID: 33928086
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in m5C modification genes are associated with survival of patients with HBV-related hepatocellular carcinoma.
Chen B; Qiu M; Gong R; Liu Y; Zhou Z; Wen Q; Wei X; Liang X; Jiang Y; Chen P; Wei Y; Huang Q; Mo Q; Lin Q; Yu H
Arch Toxicol; 2024 Apr; 98(4):1125-1134. PubMed ID: 38438738
[TBL] [Abstract][Full Text] [Related]
14. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma.
Li D; Li K; Zhang W; Yang KW; Mu DA; Jiang GJ; Shi RS; Ke D
Front Immunol; 2022; 13():918140. PubMed ID: 35833147
[TBL] [Abstract][Full Text] [Related]
15. ALYREF-mediated RNA 5-Methylcytosine modification Promotes Hepatocellular Carcinoma Progression Via Stabilizing EGFR mRNA and pSTAT3 activation.
Nulali J; Zhang K; Long M; Wan Y; Liu Y; Zhang Q; Yang L; Hao J; Yang L; Song H
Int J Biol Sci; 2024; 20(1):331-346. PubMed ID: 38164181
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the Divergent Gene Expression Landscapes of m6A/m5C/m1A Methylation Regulators in Hepatocellular Carcinoma Through Single-Cell and Bulk RNA Transcriptomic Analysis.
Liu HT; Rau CS; Liu YW; Hsieh TM; Huang CY; Chien PC; Lin HP; Wu CJ; Chuang PC; Hsieh CH
J Hepatocell Carcinoma; 2023; 10():2383-2395. PubMed ID: 38164510
[TBL] [Abstract][Full Text] [Related]
17. miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma.
Wu H; Zhang W; Wu Z; Liu Y; Shi Y; Gong J; Shen W; Liu C
Cell Death Dis; 2019 Jan; 10(2):48. PubMed ID: 30718452
[TBL] [Abstract][Full Text] [Related]
18. Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1.
Liu C; Liu L; Chen X; Shen J; Shan J; Xu Y; Yang Z; Wu L; Xia F; Bie P; Cui Y; Bian XW; Qian C
PLoS One; 2013; 8(5):e62828. PubMed ID: 23671639
[TBL] [Abstract][Full Text] [Related]
19. Human NOP2/NSUN1 regulates ribosome biogenesis through non-catalytic complex formation with box C/D snoRNPs.
Liao H; Gaur A; McConie H; Shekar A; Wang K; Chang JT; Breton G; Denicourt C
Nucleic Acids Res; 2022 Oct; 50(18):10695-10716. PubMed ID: 36161484
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression.
Zhang PF; Wei CY; Huang XY; Peng R; Yang X; Lu JC; Zhang C; Gao C; Cai JB; Gao PT; Gao DM; Shi GM; Ke AW; Fan J
Mol Cancer; 2019 Jun; 18(1):105. PubMed ID: 31153371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
